Codex DNA Announces Pricing of Initial Public Offering
June 17, 2021 22:16 ET | Source: Codex DNA, Inc. Codex DNA, Inc. San Diego, California, UNITED STATES
SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) Codex DNA, Inc. (“Codex DNA”), creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, today announced the pricing of its initial public offering of 6,666,665 shares of its common stock at a public offering price of $16.00 per share. All of the shares are being offered by Codex DNA. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Codex DNA, are expected to be $106.7 million. The shares are expected to begin trading on the Nasdaq Global Select Market on June 18, 2021, under the ticker symbol “DNAY.” The offering is expected to close on June 22, 2021, subject to the satisfaction
Investegate |Hutchmed China Ltd Announcements | Hutchmed China Ltd: HUTCHMED Launches Hong Kong IPO
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Hutchison China MediTech Limited (AIM:HCM) | RNS | Hutchmed China Ltd - HUTCHMED Launches Hong Kong IPO
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Verve Therapeutics Announces Pricing of Initial Public Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.